Technology
Health
Biotechnology

Alliqua BioMedical

$2.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (2.05%) Today
-$0.04 (-1.46%) After Hours

Why Robinhood?

You can buy or sell ALQA and other stocks, options, ETFs, and crypto commission-free!

About

Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. Read More It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA.

Employees
6
Headquarters
Langhorne, Pennsylvania
Founded
1997
Market Cap
13.44M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
414.63K
High Today
$2.80
Low Today
$2.65
Open Price
$2.66
Volume
96.19K
52 Week High
$5.24
52 Week Low
$1.55

Collections

Technology
Health
Biotechnology
Medical
Cosmetics
Retail
US
North America

News

Seeking AlphaMar 12

AquaMed Technologies files for $1.75M stock offering

AquaMed Technologies, in connection with the planned spinoff by Alliqua BioMedical (NASDAQ:ALQA) has filed a preliminary prospectus for a $1.75M offering of common stock.

581
MarketBeatMar 10

Stock Price, News, & Analysis for Alliqua Biomedical

News coverage about ALQA stock has been trending positive this week, according to InfoTrie. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Alliqua Biomedical earned a media sentiment score of 2.1 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 1.0 out of 10, indicating that recent...

8

Earnings

-$1.19
-$0.82
-$0.46
-$0.09
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
Expected Mar 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.